Cell and Gene therapy

How Cereblis Can Elevate the Potential of Salesforce’s New Life Sciences Cloud Launch for Clients

Post Author:Dinesh
Post published:October 23, 2023
Post Category:Biotech / Cell and Gene therapy / Commercialization / Digital Transformation / Pharma
Post Comments:0 Comments

Salesforce's Life Sciences Cloud is set to be a game-changer for the industry. But like any tool, its success in a company hinges on its implementation and adoption. With Cereblis's expertise in both Salesforce and the life sciences sector, clients are assured of a partner who understands their challenges and can guide them to success in this new digital era.

Investigator Initiated Trials (IIT), Investigator Initiated Research (IIR), and Grants Management: Digitization with Salesforce Experience Cloud

Post Author:Dinesh
Post published:October 18, 2023
Post Category:Biotech / Cell and Gene therapy / Clinical Research / IIT / Market Access / Pharma / Salesforce
Post Comments:0 Comments

Investigator Initiated Trials (IIT), Investigator Initiated Research (IIR), and Grants Management are vital components of advancing medical research. Salesforce Experience Cloud offers a comprehensive solution for digitizing and streamlining these processes, ensuring efficient management, compliance, and collaboration among stakeholders. By harnessing the power of Salesforce Experience Cloud, research institutions can accelerate the pace of discovery and make a meaningful impact on patient care and scientific knowledge.

Unlocking the Power of Patient Services Program Capabilities

Post Author:Dinesh
Post published:October 4, 2023
Post Category:Biotech / Cell and Gene therapy / Patient Support Program / Pharma / Salesforce
Post Comments:0 Comments

Patient services programs are a vital component of modern healthcare, designed to enhance patient experiences and outcomes. Their capabilities extend from personalized support and education to financial assistance, care coordination, and leveraging technology for remote monitoring. These programs play a pivotal role in improving the overall quality of care, fostering patient engagement, and ensuring that individuals receive the support they need to lead healthier lives. As the healthcare landscape continues to evolve, patient services programs will remain a cornerstone of patient-centered care.

Challenges of managing PHI & PII Data in Life Sciences and How AI/ML can help

Post Author:Dinesh
Post published:October 2, 2023
Post Category:Biotech / Cell and Gene therapy / Clinical Research / Medical Devices / Medical Info / Patient Recruitment / Patient Safety / Pharma / Pharmacovigilance / Salesforce
Post Comments:0 Comments

The challenge of managing and securing sensitive data in life sciences organizations is significant and growing. However, AI/ML-based PHI and PII solutions offer a promising solution to these challenges, helping organizations protect sensitive data, comply with data protection regulations, and improve efficiency and accuracy.